Rhenman & Partners Asset Management AB

Position in DNTH — Dianthus Therapeutics, Inc. /DE/

CIK 1599882 Stockholm, V7

Position in DNTH

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$8,395,659

+$1,545,522 QoQ

Shares Held

86,127

+5.5% QoQ

Ownership

0.154%

of shares outstanding

% of Portfolio

0.79%

of 13F equity value

Holder Rank

#86

of 269 holders

Holding Since

Sep 2024

8 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Rhenman & Partners Asset Management AB holds $335,352,902 across 39 Biotechnology names. DNTH ranks #17 (2.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JAZZ	Jazz Pharmaceuticals plc	87,440	$21,070,416
2	REGN	Regeneron Pharmaceuticals, Inc.	27,390	$17,078,760
3	BMRN	Biomarin Pharmaceutical Inc	290,500	$16,622,410
4	NRIX	Nurix Therapeutics, Inc.	684,250	$16,599,905
5	MIRM	Mirum Pharmaceuticals, Inc.	139,205	$16,296,729
6	INSM	INSMED Inc	151,960	$16,201,975
7	AXSM	Axsome Therapeutics, Inc.	63,050	$15,432,748
8	VRTX	Vertex Pharmaceuticals Inc / Ma	30,685	$15,242,160

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$8,395,659	86,127	+5.5%	Shares	Sole	2026-08-13
2026-03-31	$6,850,137	81,627	-17.2%	Shares	Sole	2026-05-14
2025-12-31	$4,064,418	98,627	-43.2%	Shares	Sole	2026-02-13
2025-09-30	$6,832,222	173,627	+37.1%	Shares	Sole	2025-11-13
2025-06-30	$2,359,061	126,627	0.0%	Shares	Sole	2025-08-13
2025-03-31	$2,297,013	126,627	+11.1%	Shares	Sole	2025-05-14
2024-12-31	$2,485,200	114,000	-24.0%	Shares	Sole	2025-02-13
2024-09-30	$4,107,000	150,000	—	Shares	Sole	2024-11-13
No filing history on record for this holder in this stock.